Salix Pharmaceuticals, Ltd. news

   Watch this stock
Showing stories 1 - 10 of about 57   

Articles published

SLXP 101.06 +0.40 (0.40%)
price chart
Salix Pharmaceuticals Now Covered by Analysts at Sterne Agee (SLXP)
Salix Pharmaceuticals, Ltd. logo Sterne Agee began coverage on shares of Salix Pharmaceuticals (NASDAQ:SLXP) in a research note issued to investors on Wednesday, TheFlyOnTheWall.
Stocks Buzz- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP), ZyngaInc (NASDAQ ...  Techsonian (press release)
Related articles »  
Salix Pharmaceuticals Coverage Initiated by Analysts at Sterne Agee (SLXP)
Salix Pharmaceuticals, Ltd. logo Research analysts at Sterne Agee began coverage on shares of Salix Pharmaceuticals (NASDAQ:SLXP) in a report released on Wednesday, TheFlyOnTheWall.
Salix Pharmaceuticals Receives Average Recommendation of �Hold� from ...
Salix Pharmaceuticals, Ltd. is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a variety of gastrointestinal disorders, which are those affecting ...
Related articles »  
Can Salix Pharmaceuticals (SLXP) Continue to Surge?
One company that should be on your radar is Salix Pharmaceuticals Ltd. (SLXP - Analyst Report). The stock of this specialty pharmaceutical company has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current ...
Related articles »  
Why Salix Pharmaceuticals (SLXP) Could Be a Potential Winner
One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is Salix Pharmaceuticals Ltd. (SLXP - Analyst Report). This specialty pharmaceutical company has actually seen estimates rise over the past month ...
Related articles »  
Stock's Buzzers- Salix Pharmaceuticals, Ltd. (SLXP), North American Palladium ...
... revenue surged 30% to $257.6 million. Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) decreased -3.20% and closed at $104.99 in the last trading session with the overall traded volume of 1.67 million shares, versus the average volume of 1.19 million shares.
Trending Penny Stocks - CONSOL Energy, Inc. (CNX), Salix Pharmaceuticals ...
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP), revealed its financial and operating results for the fourth quarter and fiscal year which ended on December 31, 2013 and other business updates, counting the Company's financial outlook for 2014.
Notable Movers: Salix Pharmaceuticals, Ltd. (SLXP), Level 3 Communications ...
Las Vegas, NV - March 28, 2014 - (TechSonian) �Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced that the Company presented at the 26th Annual ROTH Conference in Laguna Niguel, CA on Tuesday, March 11, 2014 at 1:30 p.m.
Pharma Stocks on our Radar -- Research on AVANIR Pharma, Zoetis, Salix ...
On Wednesday, shares in Salix Pharmaceuticals Ltd gained 3.71% to close the day at $105.76. The stock recorded a trading volume of 0.98 million shares as compared with its three months average volume of 1.10 million shares.
Related articles »  
Legal Settlement for Astellas Pharma - Analyst Blog
Astellas Pharma carries a Zacks Rank #3 (Hold). Some better stocks in the pharma sector include Salix Pharmaceuticals Ltd. ( SLXP ), Impax Laboratories Inc .
Related articles »